The Cost-Effectiveness Of Hepatitis B Vaccination Using Heplisav Versus Engerix-B In Select Adult Populations In The United States von Kuan, R, Janssen, R, Heyward, W, Nordyke, R

Volltext

An Assessment Of The Current Literature On Apheresis Use In The Treatment Of Familial Hypercholesterolemia von Wang, A, Richhariya, A, Gandra, S.R, Calimlim, B, Kim, L, Nordyke, R

Volltext

An Assessment of the Use of Utility Data in Long-Term Cost-Effectiveness Models of Lipid Lowering Therapies von Kuan, R.K, Wang, A, Cong, Z, Zolfaghari, S, Gandra, S.R, Nordyke, R

Volltext

Hemoglobin Decline in Chemotherapy Patients Prior to and after Policy Changes Affecting Use of Erythropoiesis-Stimulating Agents: 2006 – 2009 von Hill, Jw, Cong, Z, Hess, G, McGarvey, N, Nordyke, Rj

Volltext

PMD41 ECONOMIC IMPACT OF NOVEL DIGITAL THERAPEUTICS IN DIABETES, DYSLIPIDEMIA, AND HYPERTENSION von Nordyke, R., Appelbaum, K.J., Berman, M.A.

Volltext

PHP95 Payer Perspectives on Evidence for Formulary Decision Making in the United States von Wang, A, Baerwaldt, T, Kuan, R, Nordyke, R, Halbert, R

Volltext

PCN30 DOES A LACK OF HTA REVIEW LEAD TO HIGHER PRICES FOR HIV TREATMENTS? A COMPARISON WITH ONCOLOGY TREATMENTS von Nordyke, R, Imbeah-Ampiah, R, Ng-Haing, J, Oshinowo, B, Saraf, S

Volltext

PCV29 - Hospital Budget Impact Analysis For Giapreza In The Treatment Of Severe Distributive Shock In The Intensive Care Unit von Nicholson, G, Zeng, F, Lee, C, Nordyke, R

Volltext

Giapreza For The Treatment Of Severe Distributive Shock In The Intensive Care Unit: A US Cost-Effectiveness Analysis von Nicholson, G, Zeng, F, Lee, C, Nordyke, R

Volltext

PCV44 - Giapreza For The Treatment Of Severe Distributive Shock In The Intensive Care Unit: A US Cost-Effectiveness Analysis von Nicholson, G, Zeng, F, Lee, C, Nordyke, R

Volltext

Hospital Budget Impact Analysis For Giapreza In The Treatment Of Severe Distributive Shock In The Intensive Care Unit von Nicholson, G, Zeng, F, Lee, C, Nordyke, R

Volltext

PRO70 HEALTHCARE RESOURCE UTILIZATION AMONG COMMERCIALLY INSURED COLD AGGLUTININ DISEASE PATIENTS IN THE UNITED STATES von Su, J., Bylsma, L.C., Jiang, X., Morales Arias, J., Jain, N., Nordyke, R.

Volltext

Vascular Access-Specific HRQOL Impacts Among Hemodialysis Patients: The Hemodialysis Access-Related QOL (HARQ) Project Focus Group Results von Nordyke, R, Hedgeman, E, Nicholson, G, Dahl, S, Gage, S, Lithgow, T, Hays, R, Peipert, J

Volltext

PUK18 - Vascular Access-Specific HRQOL Impacts Among Hemodialysis Patients: The Hemodialysis Access-Related QOL (HARQ) Project Focus Group Results von Nordyke, R, Hedgeman, E, Nicholson, G, Dahl, S, Gage, S, Lithgow, T, Hays, R, Peipert, J

Volltext

HPR150 Beyond the Headline: Inflation-Adjusting ICER's Unsupported Price Increase Results von Wagner, TD, Westrich, K, Nordyke, RJ, Campbell, JD

Volltext

Optimal Iodine-131 Dose for Eliminating Hyperthyroidism in Graves' Disease von Nordyke, Robert A, Gilbert, Fred I., Jr

Volltext

Misdiagnosis of COPD and Asthma in Primary Care Patients 40 Years of Age and Over von Tinkelman, David G., Price, David B., Nordyke, Robert J., Halbert, R. J.

Volltext

Patient-level costs of major cardiovascular conditions: a review of the international literature von Nicholson, Gina, Gandra, Shravanthi R, Halbert, Ronald J, Richhariya, Akshara, Nordyke, Robert J

Volltext

PIN69 - The Cost-Effectiveness Of Hepatitis B Vaccination Using Heplisav Versus Engerix-B In Select Adult Populations In The United States von Kuan, R., Janssen, R., Heyward, W., Nordyke, R.

Volltext

Cost-effectiveness of hepatitis B vaccination using HEPLISAV in selected adult populations compared to Engerix-B registered vaccine von Kuan, R K, Janssen, R, Heyward, W, Bennett, S, Nordyke, R

Volltext